# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Castleman's Disease

Angiofollicular ganglionic hyperplasia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 28 results.
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
Status: Active, not recruiting
Last Changed: Apr 02, 2020
First Received: May 01, 2019
Disease(s): Castleman Disease, Castleman's Disease, Multicentric
Intervention(s): Sirolimus
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jun 12, 2019
Disease(s): Idiopathic Multicentric Castleman's Disease
Intervention(s): Bortezomib, Cyclophosphamide, Dexamethason
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
Status: Completed
Last Changed: May 22, 2018
First Received: Jul 22, 2011
Disease(s): Multicentric Castleman's Disease
Intervention(s): Siltuximab
Locations: Little Rock, Arkansas, United States
Tampa, Florida, United States
Lansing, Michigan, United States
Chapel Hill, North Carolina, United States
Greenville, South Carolina, United States
... and 22 other locations.
A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
Status: Completed
Last Changed: Nov 02, 2016
First Received: Aug 17, 2010
Disease(s): Castleman's Disease
Intervention(s): tocilizumab [RoActemra/Actemra]
Locations: Little Rock, Arkansas, United States
A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
Status: Completed
Last Changed: Mar 21, 2018
First Received: Dec 02, 2009
Disease(s): Multicentric Castleman's Disease
Intervention(s): Siltuximab, Placebo, Best Supportive Care (BSC)
Locations: Little Rock, Arkansas, United States
Los Angeles, California, United States
Tampa, Florida, United States
Boston, Massachusetts, United States
Lansing, Michigan, United States
... and 53 other locations.
TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
Status: Active, not recruiting
Last Changed: Apr 16, 2020
First Received: Feb 03, 2017
Disease(s): Multicentric Castleman Disease
Intervention(s): Thalidomide, cyclophosphamide and prednisone
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Status: Active, not recruiting
Last Changed: Jun 23, 2020
First Received: Sep 27, 2011
Disease(s): Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia
Intervention(s): Zidovudine, Tocilizumab, Valganciclovir (VGC)
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
Status: Withdrawn
Last Changed: Apr 18, 2017
First Received: Aug 09, 2006
Disease(s): Giant Lymph Node Hyperplasia
Intervention(s): Valganciclovir
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Status: Terminated
Last Changed: Jan 12, 2007
First Received: Aug 08, 2005
Disease(s): HIV Infections, Giant Lymph Node Hyperplasia
Intervention(s): Rituximab
Castleman Disease Collaborative Network Biobank
Status: Withdrawn
Last Changed: Jul 31, 2018
First Received: Aug 18, 2016
Disease(s): Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia, Angiofollicular Lymph Hyperplasia, Angiofollicular Lymph Node Hyperplasia, Angiofollicular Lymphoid Hyperplasia, GLNH, Hyperplasia, Giant Lymph Node
Intervention(s): Sample Collection
Locations: Castleman Disease Collaborative Network, Philadelphia, Pennsylvania, United States